Wearable technology for pregnant women with Type 1 Diabetes

Dawn Adams

Wearable technology for pregnant women with Type 1 Diabetes

Dawn Adams

School of Computing

Research output: Contribution to conference › Poster › peer-review

Abstract

Type 1 Diabetes (T1D) is a chronic auto-immune
condition. Pregnancies in this population are high risk for both mother & baby.
Pregnancy management for women with T1D involves:
Glucose monitoring, 8-12 times daily
Insulin administration, 4-8 times daily
Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios
Participating in regular physical activity (PA).

Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

Original language	English
Pages	1
Number of pages	1
Publication status	Published (in print/issue) - 8 Jun 2021
Event	32nd International Confederation of Midwives Virtual Triennial Congress - Online Duration: 2 Jun 2021 → 30 Jun 2021 https://www.icmvirtualcongress.org/

Conference

Conference	32nd International Confederation of Midwives Virtual Triennial Congress
Abbreviated title	ICM
Period	2/06/21 → 30/06/21
Internet address	https://www.icmvirtualcongress.org/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 10 Reduced Inequalities

Keywords

integrating data
wearable technologies
pregnant women
T1D
pregnancy
maternal outcomes
foetal outcomes

Integrated Care for Pregnant Women with Type One Diabetes using Wearable Technology
Adams, D., Zheng, H., Sinclair, M., Murphy, M. H. & Mc Cullough, J., 18 Nov 2019, BIBE 2019; The Third International Conference on Biological Information and Biomedical Engineering. VDE Verlag, 5 p.
Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Open Access
File

Cite this

@conference{0a332f197fba45d3a0c80f2daf92fddf,

title = "Wearable technology for pregnant women with Type 1 Diabetes",

abstract = "Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother \& baby. Pregnancy management for women with T1D involves: Glucose monitoring, 8-12 times daily Insulin administration, 4-8 times daily Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios Participating in regular physical activity (PA). Advances in insulin therapy \& glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management. ",

keywords = "integrating data, wearable technologies, pregnant women, T1D, pregnancy, maternal outcomes, foetal outcomes",

author = "Dawn Adams",

year = "2021",

month = jun,

day = "8",

language = "English",

pages = "1",

note = "32nd International Confederation of Midwives Virtual Triennial Congress, ICM ; Conference date: 02-06-2021 Through 30-06-2021",

url = "https://www.icmvirtualcongress.org/",

}

TY - CONF

T1 - Wearable technology for pregnant women with Type 1 Diabetes

AU - Adams, Dawn

PY - 2021/6/8

Y1 - 2021/6/8

N2 - Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother & baby. Pregnancy management for women with T1D involves: Glucose monitoring, 8-12 times daily Insulin administration, 4-8 times daily Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios Participating in regular physical activity (PA). Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

AB - Type 1 Diabetes (T1D) is a chronic auto-immune condition. Pregnancies in this population are high risk for both mother & baby. Pregnancy management for women with T1D involves: Glucose monitoring, 8-12 times daily Insulin administration, 4-8 times daily Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios Participating in regular physical activity (PA). Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.

KW - integrating data

KW - wearable technologies

KW - pregnant women

KW - T1D

KW - pregnancy

KW - maternal outcomes

KW - foetal outcomes

M3 - Poster

SP - 1

T2 - 32nd International Confederation of Midwives Virtual Triennial Congress

Y2 - 2 June 2021 through 30 June 2021

ER -

Wearable technology for pregnant women with Type 1 Diabetes

Abstract

Conference

UN SDGs

Keywords

Fingerprint

Research output

Integrated Care for Pregnant Women with Type One Diabetes using Wearable Technology

Cite this